Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01319526 · ClinicalTrials.gov registry record
Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy
A clinical trial, sponsored by AIDS Malignancy Consortium.
- Terminated
- Registry status
- 1
- Enrollment target
NCT01319526 is a clinical trial that was terminated before completion, run by AIDS Malignancy Consortium. The registered enrollment target is 1 participants.
The verdict
NCT01319526 was terminated before completion, sponsored by AIDS Malignancy Consortium.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of blood in the laboratory from patients undergoing treatment with HIV infection and Hodgkin lymphoma may help doctors learn more about the effects of therapy on HIV. PURPOSE: This research study is studying biomarkers in blood samples from patients with HIV infection and stage III or stage IV Hodgkin lymphoma undergoing chemotherapy.
Interventions
- OTHER laboratory biomarker analysis
- GENETIC DNA analysis
- GENETIC RNA analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-06 |
| Est. Completion | 2013-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01319526
The ClinicalTrials.gov registry entry for NCT01319526 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 1 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is AIDS Malignancy Consortium, which has 45 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which laboratory biomarker analysis is the first listed.
NCT01319526 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01319526 about?
NCT01319526 is a clinical study titled "Biomarkers in Blood Samples From Patients With HIV Infection and Stage III or Stage IV Hodgkin Lymphoma Undergoing Chemotherapy". RATIONALE: Studying samples of blood in the laboratory from patients undergoing treatment with HIV infection and Hodgkin lymphoma may help doctors learn more about the effects of therapy on HIV. PURPOSE: This research study is studying biomarkers in blood samples from patients with HIV infection an...
What is the current status of trial NCT01319526?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2011-06. Estimated completion is 2013-01.
What interventions are being tested in trial NCT01319526?
The interventions under investigation include: laboratory biomarker analysis (OTHER), DNA analysis (GENETIC), RNA analysis (GENETIC).
Who is sponsoring clinical trial NCT01319526?
This trial is sponsored by AIDS Malignancy Consortium, which has 45 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.